First human test for new malaria shot begins
NCT ID NCT06558643
Summary
This study is the first time a new long-acting injection for malaria is being tested in people. Its main goal is to check if the injection is safe and how the body handles it. The study involves 24 healthy volunteers who receive a single shot at one of three increasing doses or a placebo. Researchers closely monitor participants for side effects, especially at the injection site, and track how long the drug stays in the body over 12 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA,FALCIPARUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Quotient Sciences
Ruddington, Nottingham, NG11 6JS, United Kingdom
Conditions
Explore the condition pages connected to this study.